Neuroprotection mediated through estrogen receptor-α in astrocytes

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 21, 2011, Pages 8867-8872

  Spence, Rory D ^a   Hamby, Mary E ^a   Umeda, Elizabeth ^a   Itoh, Noriko ^a   Du, Sienmi ^a   Wisdom, Amy J ^a   Cao, Yuan ^a   Bondar, Galyna ^a   Lama, Jeannie ^a   Ao, Yan ^a   Sandoval, Francisco ^a   Suriany, Silvie ^a   Sofroniew, Michael V ^a   Voskuhl, Rhonda R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Astrogliosis; Conditional knockout; Multiple sclerosis

Indexed keywords

ESTROGEN RECEPTOR ALPHA; MESSENGER RNA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CONTROLLED STUDY; FEMALE; GENE DELETION; MACROPHAGE; MALE; MOUSE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANIMALS; ASTROCYTES; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ESTROGEN RECEPTOR ALPHA; INFLAMMATION; LIGANDS; MICE; MICE, KNOCKOUT; NEURODEGENERATIVE DISEASES; NEURONS; NEUROPROTECTIVE AGENTS;

MUS;

EID: 79957723865     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1103833108     Document Type: Article

References (27)

1. Brinton RD (2008) Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer's disease. Adv Drug Deliv Rev 60:1504-1511.
2. Lee SJ, McEwen BS (2001) Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. Annu Rev Pharmacol Toxicol 41:569-591. (Pubitemid 32385899)
3. Wise PM (2002) Estrogens and neuroprotection. Trends Endocrinol Metab 13:229-230.
4. KimS, Liva SM, Dalal MA, Verity MA, Voskuhl RR (1999) Estriol ameliorates autoimmune demyelinating disease: Implications for multiple sclerosis. Neurology 52:1230-1238. (Pubitemid 29177927)
5. Trapp BD, Nave K-A (2008) Multiple sclerosis: An immune or neurodegenerative disorder? Annu Rev Neurosci 31:247-269.
6. Morales LBJ, et al. (2006) Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis. J Neurosci 26:6823-6833. (Pubitemid 44315243)
7. Polanczyk M, et al. (2003) The protective effect of 17beta-estradiol on experimental autoimmune encephalomyelitis is mediated through estrogen receptor-alpha. Am J Pathol 163:1599-1605. (Pubitemid 37175106)
8. Tiwari-Woodruff S, Morales LBJ, Lee R, Voskuhl RR (2007) Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment. Proc Natl Acad Sci USA 104:14813-14818. (Pubitemid 350003225)
9. Garidou L, et al. (2004) Estrogen receptor alpha signaling in inflammatory leukocytes is dispensable for 17beta-estradiol-mediated inhibition of experimental autoimmune encephalomyelitis. J Immunol 173:2435-2442. (Pubitemid 39063100)
10. Pérez SE, Chen E-Y, Mufson EJ (2003) Distribution of estrogen receptor alpha and beta immunoreactive profiles in the postnatal rat brain. Brain Res Dev Brain Res 145:117-139. (Pubitemid 38368647)
11. García-Ovejero D, Veiga S, García-Segura LM, Doncarlos LL (2002) Glial expression of estrogen and androgen receptors after rat brain injury. J Comp Neurol 450:256-271. (Pubitemid 34809996)
12. Mitra SW, et al. (2003) Immunolocalization of estrogen receptor beta in the mouse brain: Comparison with estrogen receptor alpha. Endocrinology 144:2055-2067. (Pubitemid 36543346)
13. Barres BA (2008) The mystery and magic of glia: A perspective on their roles in health and disease. Neuron 60:430-440.
14. Freeman MR (2010) Specification andmorphogenesis of astrocytes. Science 330:774-778.
15. Voskuhl RR, et al. (2009) Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. JNeurosci 29:11511-11522.
16. Sofroniew MV (2009) Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 32:638-647.
17. Kwon C-H, et al. (2006) Neuron-specific enolase-cre mouse line with cre activity in specific neuronal populations. Genesis 44:130-135.
18. Forss-Petter S, et al. (1990) Transgenic mice expressing beta-galactosidase in mature neurons under neuron-specific enolase promoter control. Neuron 5:187-197. (Pubitemid 20262697)
19. Herrmann JE, et al. (2008) STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J Neurosci 28:7231-7243.
20. Dupont S, et al. (2000) Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 127:4277-4291.
21. Giraud SN, Caron CM, Pham-Dinh D, Kitabgi P, Nicot AB (2010) Estradiol inhibits ongoing autoimmune neuroinflammation and NFkappaB-dependent CCL2 expression in reactive astrocytes. Proc Natl Acad Sci USA 107:8416-8421.
22. Wujek JR, et al. (2002) Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. J Neuropathol Exp Neurol 61:23-32. (Pubitemid 34027718)
23. Jazin E, Cahill L (2010) Sex differences in molecular neuroscience: From fruit flies to humans. Nat Rev Neurosci 11:9-17.
24. Chaovipoch P, et al. (2006) 17beta-estradiol is protective in spinal cord injury in postand pre-menopausal rats. J Neurotrauma 23:830-852. (Pubitemid 43962845)
25. Dubal DB, et al. (2001) Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci USA 98:1952-1957. (Pubitemid 32165604)
26. Sherwin BB (2007) The clinical relevance of the relationship between estrogen and cognition in women. J Steroid Biochem Mol Biol 106:151-156.
27. Cerciat M, Unkila M, Garcia-Segura LM, Arevalo MA (2010) Selective estrogen receptor modulators decrease the production of interleukin-6 and interferongamma-inducible protein-10 by astrocytes exposed to inflammatory challenge in vitro. Glia 58:93-102.